Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.

[This corrects the article DOI: 10.1371/journal.pone.0173299.].

There are errors in the author affiliations. The affiliations should appear as shown here: Garrick D. Talmage1, Oscar J. M. Coppes2, Adil Javed3, Jacqueline Bernard4

1 Department of Otolaryngology, University of Colorado, Aurora, Colorado, United States of America, 2 Department of Anesthesia, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 3 Department of Neurology, The University of Chicago, Chicago, Illinois, United States of America, 4 Department of Neurology, Oregon Health Science University, Portland, Oregon, United States of America.